CAM
ASTX

Capstone Asset Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Capstone Asset Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,515
Closed -$89K – 2057
2013
Q3 		$89K Hold
10,515
– – ﹤0.01% 1957
2013
Q2 		$43K Buy
+10,515
New +$56.5K ﹤0.01% 1943

Capstone Asset Management's ASTX Position: Q4 2013 in Review

Capstone Asset Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 10,515 shares — an estimated $89K sold.

Capstone Asset Management first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $89K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Capstone Asset Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Capstone Asset Management sold 10,515 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $89K.
  • Capstone Asset Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Capstone Asset Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $89K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Capstone Asset Management's 13F filing for Q4 2013, filed 4 Feb 2014.